SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

A project grown out of the community's love and passion for the weed culture. Launched around early 2025, $weedcoin, “Like Bitcoin but way higher,” emphasizes its alignment with cannabis culture and a laid-back vibe. Unlike other Weed communities, this project leans heavily into community engagement over technical utility, aiming to build a “stoner community” through social media presence and decentralized governance. We also aim to focus on onboarding web2 businesses and users onto web3 through the token.

Weedcoin

Weedcoin is buzzing with its community emphasizing a strong "culture" and long-term vision, as anticipation builds for the upcoming 4/20 event and the broader movement to deschedule cannabis. The crypto is positioned as "Bitcoin but way higher," fostering discussions on its potential for decentralized payments within the evolving cannabis industry.

ImmunityBio, Inc. is a clinical stage immunotherapy company. It develops next generation therapies that drive immunogenic mechanisms for defeating cancers and infectious diseases. The company's immunotherapy platform activates both the innate and adaptive immune systems to create long term immunological memory. ImmunityBio was founded by Patrick Soon-Shiong in 2014 and is headquartered in San Diego, CA.

ImmunityBio Inc

ImmunityBio is trending as the community eagerly anticipates CEO Dr. Patrick Soon-Shiong's upcoming high-profile media appearances and an imminent investor conference call, fueling discussions about potential regulatory advancements for Anktiva, significant international partnerships, and the possibility of a short squeeze against perceived market manipulation.

BioCryst Pharmaceuticals, Inc. is a biotechnology company. It engages in the provision of structure-guided drug design with the goal of developing oral small-molecule and protein therapeutics to target difficult-to-treat rare diseases. The company was founded by William M. Spencer III, Charles E. Bugg, and John A. Montgomery in 1986 and is headquartered in Durham, NC.

Biocryst Pharmaceuticals Inc.

Biocryst Pharmaceuticals is trending as the community debates its Q4 earnings results and anticipates new data on its HAE pipeline, particularly navenibart, at upcoming healthcare conferences; high short interest and institutional activity are amplifying discussions around a potential short squeeze and the company's long-term value.

Paramount Skydance Corp. is a next-generation global media and entertainment company that engages in providing content creation and distribution services. It operates through the following business segments: Studios, Direct-to-Consumer, and TV Media. Its portfolio unites brands including Paramount Pictures, Paramount Television, CBS, CBS News, Nickelodeon, MTV, BET, Comedy Central, Showtime, Paramount Plus, Pluto TV, and Skydance’s Animation, Film, Television, Interactive/Games, and Sports divisions. The company was founded on June 3, 2024 and is headquartered in New York, NY.

Paramount Skydance Corp. - Ordinary Shares - Class B

Paramount Skydance is trending as its offer for Warner Bros. Discovery was deemed superior, leading Netflix to withdraw its competing bid. The community is buzzing with excitement over the formation of a potential new media powerhouse with an expansive content and sports library, while also debating the strategic implications of the significant debt involved.

Battalion Oil Corp. engages in the acquisition, production, exploration, and development of liquids-rich oil and natural gas assets in the Delaware Basin. The company was founded in 1987 and is headquartered in Houston, TX.

Battalion Oil Corp - Ordinary Shares (New)

Battalion Oil Corp is seeing increased attention amid escalating geopolitical tensions involving Iran, with the community actively debating the potential for military action to impact oil prices. This speculation, combined with recent debt reduction and a favorable technical setup, is fueling discussions around a potential short squeeze in the oil and gas sector.

The Goldman Sachs Group, Inc. engages in the provision of financial services. It operates through the following business segments: Global Banking and Markets, Asset and Wealth Management, and Platform Solutions. The Global Banking and Markets segment includes investment banking, global investments, and equity and debt investments. The Asset and Wealth Management segment relates to the direct-to-consumer banking business which includes lending, deposit-taking, and investing. The Platform Solutions segment includes consumer platforms such as partnerships offering credit cards and point-of-sale financing, and transaction banking. The company was founded by Marcus Goldman in 1869 and is headquartered in New York, NY.

Goldman Sachs Group, Inc.

Goldman Sachs is trending following its Q4 earnings, which showed a profit beat and dividend hike powered by strong investment banking and trading, despite a revenue miss attributed to its Apple Card divestment. The community is actively debating if its leadership confirms a strengthening financial sector amid evolving market conditions.

Aldeyra Therapeutics, Inc. is a biotechnology company, which engages in research and development activities with related general business planning, including raising capital. It engages in the discovery of therapies designed to treat immune-mediated diseases. The company was founded by Thomas A. Jordan and John E. Dowling on August 13, 2004 and is headquartered in Lexington, MA.

Aldeyra Therapeutics Inc

Aldeyra Therapeutics is seeing intense debate as its PDUFA for a dry eye treatment was extended to March 16, 2026, following an FDA request for data from a trial that missed its primary endpoint, leading bulls to cite a draft label and CEO confidence while bears emphasize past rejections, cash runway concerns, and a key executive's departure.

Aardvark Therapeutics, Inc. operates as a biotechnology company. It engages in the development of a novel, small-molecule therapeutics for the treatment of metabolic diseases. The company was founded by Tien Lee in 2017 and is headquartered in San Diego, CA.

Aardvark Therapeutics Inc.

Aardvark Therapeutics Inc

Aardvark Therapeutics is under intense scrutiny after voluntarily pausing its Phase 3 ARD-101 trial for Prader-Willi syndrome following reversible cardiac signals at high doses, prompting significant bearish sentiment and community questions about the therapy's future and management's past decisions.

Hawaiian Electric Industries, Inc. is a holding company, which engages in electric utility and non-regulated renewable and sustainable infrastructure businesses. The company was founded by C. Dudley Pratt Jr. in 1981 and is headquartered in Honolulu, HI.

Hawaiian Electric Industries, Inc.

Hawaiian Electric Industries is trending due to its significantly improved Q4 2025 earnings and key legislative actions that mitigate future wildfire liability risks, signaling a path towards financial recovery. The community is actively discussing these positive developments, with many investors anticipating long-term growth and potential dividend reinstatement, further bolstered by substantial institutional accumulation.

Applied Optoelectronics, Inc. engages in the design and manufacture of optical communications products. Its products include optical devices, such as laser diodes, photodiodes, related modules and circuitry, and equipment for applications in fiber-to-the-home, cable television, point to point communications, and wireless. The company was founded by Chih Hsiang Lin on February 28, 1997 and is headquartered in Sugar Land, TX.

Applied Optoelectronics Inc

Applied Optoelectronics is experiencing a massive surge following a significant earnings beat and upbeat guidance, fueled by robust demand for its 800G transceivers in AI data centers. This parabolic rally has ignited fervent community debate regarding its current extreme valuation and the potential impact of a recent at-the-market offering, amid broader sector enthusiasm for photonics.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Nebius Group (NASDAQ:NBIS) Stock Price Down 13.1% - Here's Why

Nebius Group (NASDAQ:NBIS) Trading Down 13.1% - Here's What Happened...

Why Nebius Group Stock Was Down Double-Digits Today

Key PointsCoreWeave reported a widening loss and weak guidance in its Q4 report...

<ul class="summary-bullets"><li>Nebius and CoreWeave are both neocloud or artificial intelligence infrastructure providers with GPU-first data centers.&nbsp;</li><li>Retail touted the dip in NBIS stock as a ‘buying opportunity,’ while also calling the company’s shares superior to CoreWeave’s because of its lower leverage.</li><li>CoreWeave has long-term debt of $14.67 billion as of Dec. 31, 2025, while Nebius has long-term debt of $4.1 billion as of the same date.</li></ul>Shares of Amsterdam-based Nebius Group N.V. (NBIS) slumped more than 13% on Friday amid a decline in rival CoreWeave Inc.'s (CRWV) shares. &nbsp;CoreWeave on Thursday <a href="https://stocktwits.com/news-articles/markets/equity/crwv-stock-slumps-on-coreweave-capex-projections-for-2026/cZTcmZKRITh">announced</a> that its capital expenditure plans for 2026 would be more than double of 2025, sending its shares down in Friday’s trade.Nebius and CoreWeave are both neocloud or artificial intelligence infrastructure providers with GPU-first data centers. Both companies are backed by Nvidia Corp. (NVDA) and operate on its chips.<h2 class="st-heading-2">What Is Retail Saying?</h2>On Stocktwits, retail sentiment around NBIS shares was in the ‘bullish’ territory amid ‘normal’ message volumes at the time of writing. The stock was among the most-trending on the platform.One bullish user said that CoreWeave’s dip just gave the market an ‘incredible buying opportunity.’<stembedurl>https://stocktwits.com/dailyalpha_2228/message/646097684</stembedurl>&nbsp;Another bullish user said that compute would be the future of the market and called it a ‘gift dip’.<stembedurl>https://stocktwits.com/Source206/message/646123644</stembedurl>&nbsp;A third user called Nebius the ‘winner’ when compared to CoreWeave.<stembedurl>https://stocktwits.com/omz24/message/646121668</stembedurl>&nbsp;Another bullish user gave Nebius the thumbs up, while giving CoreWeave a thumbs down, citing capital structure differences.<stembedurl>https://stocktwits.com/santacruztodd/message/646047422</stembedurl>&nbsp;<h2 class="st-heading-2">Capital Expenditure</h2>For 2026, CoreWeave has forecasted capital expenditure of $30 billion to $35 billion in 2026, compared to $14.9 billion spent in 2025. The company also reported long-term debt of $14.67 billion as of Dec. 31, 2025, compared to $5.4 billion as of Dec. 31, 2024.<figure class="image"><img src="https://news.stocktwits-cdn.com/Core_Weave_Long_Term_Debt_jpg_36378b7d22.webp" alt="CoreWeave_Long-Term_Debt.jpg" width="1600" height="1134"><figcaption>CoreWeave Debt From Dec. 2023 to Dec. 2025 | Source: Fiscal.ai</figcaption></figure>&nbsp;In comparison, Nebius reported long-term debt of $4.1 billion as of Dec. 31, 2025, a notable increase from zero debt the previous year, as it catches up to growing competition in the AI cloud market. Yet, its debt is significantly lower than that of CoreWeave’s.<figure class="image"><img src="https://news.stocktwits-cdn.com/Nebius_Group_Long_Term_Debt_jpg_898dd44895.webp" alt="Nebius_Group_Long-Term_Debt.jpg" width="1600" height="1134"><figcaption>Nebius had near-zero debt in 2023 and 2024 | Source: Fiscal.ai</figcaption></figure>&nbsp;However, Arkady Volozh, founder and CEO of Nebius, said in a <a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://assets.nebius.com/assets/e59fb92e-9027-473a-8cac-04f9d2e9ea9a/Shareholder%20Letter%20Q4%202025.pdf?cache-buster=2026-02-12T11:43:13.446Z">letter to shareholders</a> on Feb. 12 that the company would “maintain a disciplined approach to raising capital” even as it considers a range of financing options for 2026, including corporate debt and asset-backed financing.<a href="https://stocktwits.com/symbol/NBIS">Shares of NBIS</a> have risen more than 178% in the past year, while s<a href="https://stocktwits.com/symbol/CRWV">hares of CRWV</a> have gained more than 93% in the same period.For updates and corrections, email newsroom[at]stocktwits[dot]com.Also Read: <a href="https://stocktwits.com/news-articles/markets/equity/coreweave-ceo-justifies-capex-spend-amid-stock-price-plummet-touts-high-demand/cZTcYsFRIT8">CoreWeave CEO Justifies Capex Spend Amid Stock Price Plummet, Touts High Demand: ‘Our Backlog Is Enormous’</a>

In this photo illustration, the Nebius Group logo is seen displayed on a smartphone screen. 

NBIS Stock Tanks Amid CoreWeave Decline — What Does Retail Think? 

CoreWeave on Thursday announced that its capital expenditure plans for 2026 would be more than double of 2025, sending its shares down in Friday’s trade. 

NBIS Stock Tanks Amid CoreWeave Decline — What Does Retail Think?

Equity

Nebius Group (NASDAQ:NBIS) Shares Gap Down - Time to Sell?

Nebius Group (NASDAQ:NBIS) Shares Gap Down - Here's Why...

Fifth Lane Capital LP Sells 14,400 Shares of Nebius Group N.V. $NBIS

Fifth Lane Capital LP reduced its holdings in shares of Nebius Group N.V. (NASDAQ:NBIS - Free Report) by 75.8% in the third quarter, according to the company in its most recent disclosure with the...

Massive News: Nebius Just Made a Bold AI Acquisition That Could Change Everything

Nebius Group N.V. (NASDAQ: NBIS) just posted 479% revenue growth and made a strategic $275M acquisition to expand into agentic AI infrastructure. If AI agents become core to enterprise workflows...

Nebius Group (NASDAQ:NBIS) Trading Down 1.2% - What's Next?

Nebius Group (NASDAQ:NBIS) Stock Price Down 1.2% - What's Next...

Nebius vs. Alphabet: Which AI Cloud Stock is the Better Buy?

NBIS AI cloud revenue surges 830% while GOOGL leverages AI to boost search, YouTube and Google Cloud growth.

Virtus Wealth Solutions LLC Decreases Holdings in Nebius Group N.V. $NBIS

Virtus Wealth Solutions LLC trimmed its holdings in Nebius Group N.V. (NASDAQ:NBIS - Free Report) by 84.6% in the third quarter, according to the company in its most recent filing with the SEC. The...

Total Clarity Wealth Management Inc. Purchases Shares of 10,859 Nebius Group N.V. $NBIS

Total Clarity Wealth Management Inc. purchased a new position in shares of Nebius Group N.V. (NASDAQ:NBIS - Free Report) during the 3rd quarter, according to the company in its most recent disclosure...

Nebius Group NV is a technology company that provides infrastructure and services to AI builders worldwide. It offers Nebius AI, an AI-centric cloud platform provides full-stack infrastructure, including large-scale GPU clusters, cloud services, and developer tools. The company also operates through specialized brands: Toloka AI, which partners in data for generative AI development; TripleTen, an edtech platform focused on re-skilling individuals for tech careers; and Avride, which develops autonomous driving technology. Nebius Group was founded by Elena Kolmanovskaya, Ilya Segalovich, Mikhail Fadeev, and Arkady Volozh in 1989 and is headquartered in Amsterdam, the Netherlands.

Nebius Group N.V. - Ordinary Shares - Class A

Day trading

Swing trading

Long-term investing

Sitting in cash

Markets have been volatile, with macro headlines and earnings driving sharp moves. How are you positioning right now?

Drop your approach below 👇

Stocktwits

Stocktwits Polls

Nebius Group N.V. 

Traders are vocal about the stock's significant decline, attributing it to a sympathetic reaction to competitor Coreweave's earnings miss and debt issues, despite its own strong fundamentals.

Many investors view the recent double-digit percentage decline as an oversold "gift" to acquire more shares, with confidence in its long-term potential.

Despite the recent steep decline, a strong sentiment exists that the stock will quickly rebound to reclaim its $100 price level next week.

Users express frustration over what they perceive as algorithmic manipulation and unfair trading practices causing erratic price movements.

NBIS
Nebius Group N.V.

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest NBIS News

NBISNebius Group N.V.